Aggressive statin therapy for acute coronary syndromes

被引：0
|
作者：
Liew T.V. [1 ]
Ray K.K. [1 ]
机构：
[1] Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge
来源：
Current Cardiology Reports | 2007年 / 9卷 / 4期
关键词：
Statin; Acute Coronary Syndrome; Atorvastatin; Pravastatin; Statin Therapy;
D O I：
10.1007/BF02938378
中图分类号：
学科分类号：
摘要：
Acute coronary syndromes (ACS) account for an enormous disease burden, especially in the Western world. Patients suffering acute coronary events are now understood to carry a very high risk of further coronary events and although improvements in conventional medical therapy over the past two decades have significantly reduced the risk, it remains high. Therapy with HMG CoA reductase inhibitors (statins) have now been well established for the primary and secondary prevention of stable coronary heart disease, but recently a substantial body of evidence has proven their efficacy in the treatment of ACS. This article examines this emerging evidence for the use of statins in ACS. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码：298 / 302
页数：4
相关论文
共 50 条
  • [31] Ezetimibe plus a Statin after Acute Coronary Syndromes
    Egom, Emmanuel E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (15): : 1474 - 1474
  • [32] Role of statin pleiotropism in acute coronary syndromes and stroke
    Liao, JK
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, : 51 - 57
  • [33] Statin-ezetimibe versus statin lipid-lowering therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention
    Dai, Yun-Yan
    Zhang, Hai-Shan
    Zhang, Xin-Gang
    Guan, Qi-Gang
    Gao, Yuan
    Li, Yu-Ze
    Zhang, Yue-Lan
    Jia, Da-Lin
    Sun, Ying-Xian
    Qi, Guo-Xian
    Tian, Wen
    [J]. JOURNAL OF THORACIC DISEASE, 2017, 9 (05) : 1345 - 1352
  • [34] Benefits of statin therapy in patients with special risks: Coronary bypass surgery, stable coronary disease, and acute coronary syndromes
    Brown, WV
    [J]. CLINICAL CARDIOLOGY, 2003, 26 (04) : 13 - 18
  • [35] Aggressive therapy for non-ST elevation acute coronary syndromes is highly effective
    RA Santos
    PS Lira
    CT Mesquita
    AL Cascardo
    RM Rocha
    FOD Rangel
    R Esporcatte
    [J]. Critical Care, 5 (Suppl 3):
  • [36] Association between Statin Therapy and Lower Incidence of Hyperglycemia in Patients Hospitalized with Acute Coronary Syndromes
    de Mendonca Furtado, Remo Holanda
    Genestreti, Paulo Rizzo
    Dalcoquio, Talia F.
    Baracioli, Luciano Moreira
    Lima, Felipe Galego
    Franci, Andre
    Giraldez, Roberto R. C., V
    Menezes, Fernando R.
    Ferrari, Aline Gehlen
    Lima, Viviane Moreira
    Pereira, Cesar A. C.
    Kenji Nakashima, Carlos Alberto
    Salsoso, Rocio
    Godoy, Lucas Colombo
    Nicolau, Jose C.
    [J]. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2021, 116 (02) : 285 - 294
  • [37] Correlation of highly sensitive C reactive protein with Acute Coronary Syndromes and effects of Statin therapy
    Varma, Y.
    Gupta, R.
    Kuchwaha, A.
    Yadav, B. S.
    Singh, G.
    Shrivastava, R. K.
    Sharma, V. K.
    Dube, T. N.
    Jain, R. K.
    Meena, R. S.
    [J]. CIRCULATION, 2008, 118 (12) : E457 - E457
  • [38] Does statin therapy improve short-term clinical outcomes in acute coronary syndromes?
    Durrington, Paul
    [J]. NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (11): : 592 - 593
  • [39] Clinical implications of switching from intensive to moderate statin therapy after acute coronary syndromes
    Colivicchi, Furio
    Tubaro, Marco
    Santini, Massimo
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 152 (01) : 56 - 60
  • [40] Cochrane corner: early statin therapy in acute coronary syndromes-what is the clinical benefit?
    Nordmann, Alain
    Schwartz, Gregory
    Vale, Noah
    Bucher, Heiner C.
    Briel, Matthias
    [J]. HEART, 2016, 102 (09) : 653 - 654
12345